Supplementary Data from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer Article Swipe
Jodi M. Carter
,
Mei‐Yin C. Polley
,
Roberto A. Leon‐Ferre
,
Jason P. Sinnwell
,
Kevin J. Thompson
,
Xue Wang
,
Yaohua Ma
,
David Zahrieh
,
Jennifer M. Kachergus
,
Malvika Solanki
,
Judy C. Boughey
,
Minetta C. Liu
,
James N. Ingle
,
Krishna R. Kalari
,
Fergus J. Couch
,
E. Aubrey Thompson
,
Matthew P. Goetz
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24263009
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24263009
Data 1
Related Topics
Concepts
Triple-negative breast cancer
Stage (stratigraphy)
Breast cancer
Immune system
Immune escape
Cancer
Oncology
Medicine
Internal medicine
Biology
Immunology
Paleontology
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.24263009
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387396985
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387396985Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.24263009Digital Object Identifier
- Title
-
Supplementary Data from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast CancerWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-06Full publication date if available
- Authors
-
Jodi M. Carter, Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, Jason P. Sinnwell, Kevin J. Thompson, Xue Wang, Yaohua Ma, David Zahrieh, Jennifer M. Kachergus, Malvika Solanki, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, E. Aubrey Thompson, Matthew P. GoetzList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.24263009Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.24263009Direct OA link when available
- Concepts
-
Triple-negative breast cancer, Stage (stratigraphy), Breast cancer, Immune system, Immune escape, Cancer, Oncology, Medicine, Internal medicine, Biology, Immunology, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387396985 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.24263009 |
| ids.doi | https://doi.org/10.1158/1078-0432.24263009 |
| ids.openalex | https://openalex.org/W4387396985 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Data from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T10619 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9954000115394592 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Esophageal Cancer Research and Treatment |
| topics[2].id | https://openalex.org/T10580 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9815999865531921 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immunotherapy and Immune Responses |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780110267 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7947473526000977 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7843332 |
| concepts[0].display_name | Triple-negative breast cancer |
| concepts[1].id | https://openalex.org/C146357865 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6677987575531006 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[1].display_name | Stage (stratigraphy) |
| concepts[2].id | https://openalex.org/C530470458 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5688555836677551 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[2].display_name | Breast cancer |
| concepts[3].id | https://openalex.org/C8891405 |
| concepts[3].level | 2 |
| concepts[3].score | 0.49687936902046204 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[3].display_name | Immune system |
| concepts[4].id | https://openalex.org/C3018558359 |
| concepts[4].level | 3 |
| concepts[4].score | 0.4274940490722656 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1660157 |
| concepts[4].display_name | Immune escape |
| concepts[5].id | https://openalex.org/C121608353 |
| concepts[5].level | 2 |
| concepts[5].score | 0.3864104151725769 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[5].display_name | Cancer |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.38314756751060486 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3155794143676758 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.24911636114120483 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.1964343786239624 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.17556801438331604 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C151730666 |
| concepts[11].level | 1 |
| concepts[11].score | 0.09330660104751587 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[11].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/triple-negative-breast-cancer |
| keywords[0].score | 0.7947473526000977 |
| keywords[0].display_name | Triple-negative breast cancer |
| keywords[1].id | https://openalex.org/keywords/stage |
| keywords[1].score | 0.6677987575531006 |
| keywords[1].display_name | Stage (stratigraphy) |
| keywords[2].id | https://openalex.org/keywords/breast-cancer |
| keywords[2].score | 0.5688555836677551 |
| keywords[2].display_name | Breast cancer |
| keywords[3].id | https://openalex.org/keywords/immune-system |
| keywords[3].score | 0.49687936902046204 |
| keywords[3].display_name | Immune system |
| keywords[4].id | https://openalex.org/keywords/immune-escape |
| keywords[4].score | 0.4274940490722656 |
| keywords[4].display_name | Immune escape |
| keywords[5].id | https://openalex.org/keywords/cancer |
| keywords[5].score | 0.3864104151725769 |
| keywords[5].display_name | Cancer |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.38314756751060486 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.3155794143676758 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.24911636114120483 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.1964343786239624 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.17556801438331604 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/paleontology |
| keywords[11].score | 0.09330660104751587 |
| keywords[11].display_name | Paleontology |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.24263009 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.24263009 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5006782806 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5973-0732 |
| authorships[0].author.display_name | Jodi M. Carter |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jodi M. Carter |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5060738532 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0106-0323 |
| authorships[1].author.display_name | Mei‐Yin C. Polley |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mei-Yin C. Polley |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5069569795 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0594-4441 |
| authorships[2].author.display_name | Roberto A. Leon‐Ferre |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Roberto A. Leon-Ferre |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5058853230 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1964-5522 |
| authorships[3].author.display_name | Jason P. Sinnwell |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jason Sinnwell |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5070464408 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9348-4686 |
| authorships[4].author.display_name | Kevin J. Thompson |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kevin J. Thompson |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5120218320 |
| authorships[5].author.orcid | https://orcid.org/0009-0002-1823-4086 |
| authorships[5].author.display_name | Xue Wang |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Xue Wang |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5102849202 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-4402-5464 |
| authorships[6].author.display_name | Yaohua Ma |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yaohua Ma |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5047094317 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0529-5146 |
| authorships[7].author.display_name | David Zahrieh |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | David Zahrieh |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5072734589 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Jennifer M. Kachergus |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Jennifer M. Kachergus |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5113962952 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-6211-1599 |
| authorships[9].author.display_name | Malvika Solanki |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Malvika Solanki |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5033544737 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3820-3228 |
| authorships[10].author.display_name | Judy C. Boughey |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Judy C. Boughey |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5027858713 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-8206-5232 |
| authorships[11].author.display_name | Minetta C. Liu |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Minetta C. Liu |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5083904553 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-1257-7731 |
| authorships[12].author.display_name | James N. Ingle |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | James N. Ingle |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5085014608 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8944-8378 |
| authorships[13].author.display_name | Krishna R. Kalari |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Krishna R. Kalari |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5016908886 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9417-9985 |
| authorships[14].author.display_name | Fergus J. Couch |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Fergus J. Couch |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5026692399 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-9001-4240 |
| authorships[15].author.display_name | E. Aubrey Thompson |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | E. Aubrey Thompson |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5008665323 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-4383-270X |
| authorships[16].author.display_name | Matthew P. Goetz |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Matthew P. Goetz |
| authorships[16].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.24263009 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Data from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W3030228103, https://openalex.org/W2903919886, https://openalex.org/W2064898491, https://openalex.org/W2117246658, https://openalex.org/W1986496754, https://openalex.org/W2056590164, https://openalex.org/W2354472550, https://openalex.org/W2066982596, https://openalex.org/W1966707677, https://openalex.org/W2891111908 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.24263009 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.24263009 |
| primary_location.id | doi:10.1158/1078-0432.24263009 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.24263009 |
| publication_date | 2023-10-06 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.1</p> | 1 |
| abstract_inverted_index.<p>Data | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 17 |
| citation_normalized_percentile.value | 0.47361864 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |